Skip to main content
. 2022 May 10;8(1):e002063. doi: 10.1136/rmdopen-2021-002063

Table 4.

Age at time of the survey Sex Body mass index (kg/m2) Comorbidities* number type Autoinflammatory disease AA amyloidosis Treatment Biologics
1 75 W 20 2 COPD Behçet disease No Steroids >10mg No
2 34 H 43 3 Obesity Diabetes HT Unclassified autoinflammatory disease No Colchicine No
3 84 M 20 4 CVD CKD AVC Still disease No Steroids> 10 mg No
4 74 W 27 3 Diabetes HT Behçet disease No Steroids>10 mg No
5 58 M 21.8 2 HT CKD** FMF Yes Colchicine IL1-inhibitor (Anakinra)
6 81 M 22.9 5 CVD CKD** COPD HT FMF No Colchicine IL1-inhibitor (Anakinra)